← Leaderboards
Vijayshree Yadav
Oregon Health And Science University
$669,600
Attributed
$669,600
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $133.9K · FY2005–25$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$669,600 · 1
VA$0 · 2
By mechanism
K23$669,600 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Cary O. Harding$9,584,438
- Julie H Carter$997,008
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryCaringDesignMultiple SclerosisClinical TrialsDoseMitochondrial DysfunctionTreatment ProgramVeteransPlayMitochondriaSurveysPathogenesisModificationQuality Of LifeDiagnosisNerve DegenerationBaseDisabilityNeuraxisResearch DesignEnrollmentAffectMultiple Sclerosis Treatment
Grant awards (18)
MitoQ for Fatigue in Multiple Sclerosis: A Placebo Controlled Trial$0
I01 · FY2025 · VA · contact PI
MitoQ for Fatigue in Multiple Sclerosis: A Placebo Controlled Trial$0
I01 · FY2024 · VA · contact PI
MitoQ for Fatigue in Multiple Sclerosis: A Placebo Controlled Trial$0
I01 · FY2023 · VA · contact PI
MitoQ for Fatigue in Multiple Sclerosis: A Placebo Controlled Trial$0
I01 · FY2022 · VA · contact PI
MitoQ for Fatigue in Multiple Sclerosis: A Placebo Controlled Trial$0
I01 · FY2021 · VA · contact PI
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism$0
I01 · FY2021 · VA · contact PI
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism$0
I01 · FY2020 · VA · contact PI
MitoQ for Fatigue in Multiple Sclerosis: A Placebo Controlled Trial$0
I01 · FY2020 · VA · contact PI
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism$0
I01 · FY2019 · VA · contact PI
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism$0
I01 · FY2018 · VA · contact PI
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism$0
I01 · FY2017 · VA · contact PI
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism$0
I01 · FY2016 · VA · contact PI
Vascular Disease Risk Factors and MS Progression: A Study of Brain Metabolism$0
I01 · FY2015 · VA · contact PI
Lipoic acid as an immune modulator in multiple sclerosis$133,920
K23 · FY2009 · AT · contact PI
Lipoic acid as an immune modulator in multiple sclerosis$133,920
K23 · FY2008 · AT · contact PI
Lipoic acid as an immune modulator in multiple sclerosis$133,920
K23 · FY2007 · AT · contact PI
Lipoic acid as an immune modulator in multiple sclerosis$133,920
K23 · FY2006 · AT · contact PI
Lipoic acid as an immune modulator in multiple sclerosis$133,920
K23 · FY2005 · AT